OXT and anxiety disorder: First, it will be investigated whether basal saliva OXT levels of children and adolescents (11–18 years of age) with a clinically diagnosed anxiety disorder (experimental group) differ significantly from OXT levels of healthy children and adolescents without a clinical psychiatric diagnosis (healthy control group).